CMB 1.27% 39.0¢ cambium bio limited

Ann: Japanese Patent Office to grant key patent for Progenza, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,134 Posts.
    lightbulb Created with Sketch. 44
    RGS has been ticking boxes all year.
    Monday's announcement was the big one. It looks like the company has a unique (via it secretions technology) and efficacious product, that has good shot at becoming a becoming a commercial proposition in a key growth market.

    It was good to see RGS expanding a bit more about Progenze in today's announcement.
    What would be good to hear as well would be about Progenza's potential for other medical conditions, with projected timelines/licensing strategies etc.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.